These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1666688)

  • 1. Inhibitory interactions between alpha 2-adrenergic and opoid but not NPY mechanisms controlling the CRF-ACTH axis in the rat.
    Gaillet S; Malaval F; Barbanel G; Pelletier G; Assenmacher I; Szafarczyk A
    Regul Pept; 1991 Oct; 36(2):249-61. PubMed ID: 1666688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog.
    Inoue T; Inui A; Okita M; Sakatani N; Oya M; Morioka H; Mizuno N; Oimomi M; Baba S
    Life Sci; 1989; 44(15):1043-51. PubMed ID: 2538698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat.
    Yamauchi N; Shibasaki T; Wakabayashi I; Demura H
    Brain Res; 1997 Nov; 777(1-2):140-6. PubMed ID: 9449422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin.
    Grino M; Paulmyer-Lacroix O; Faudon M; Renard M; Anglade G
    Endocrinology; 1994 Dec; 135(6):2549-57. PubMed ID: 7988443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog].
    Inoue T; Inui A; Okita M; Sakatani N; Oya M; Morioka H; Mizuno N; Oimomi M; Baba S
    Nihon Naibunpi Gakkai Zasshi; 1990 Jun; 66(6):607-18. PubMed ID: 2167247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Implication of alpha-2 adrenergic post-synaptic receptors in the central catecholaminergic stimulation of the corticotropic axis in rats].
    Szafarczyk A; Gaillet S; Barbanel G; Malaval F; Assenmacher I
    C R Acad Sci III; 1990; 311(2):81-8. PubMed ID: 1976425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal and PAF-, interleukin 1-, ether stress-induced hypothalamic pituitary adrenal secretion of conscious rat: modulation by PAF antagonists.
    Rougeot C; Tiberghein C; Minary P; Dray F
    J Lipid Mediat; 1991; 4(1):45-59. PubMed ID: 1654152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat.
    Rivier C; Rivier J; Lee S
    Brain Res; 1996 May; 721(1-2):83-90. PubMed ID: 8793087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the 2-deoxyglucose effect on the adrenocortical axis.
    Weidenfeld J; Corcos AP; Wohlman A; Feldman S
    Endocrinology; 1994 Apr; 134(4):1924-31. PubMed ID: 8137760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N; Kitamura K
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1984 May; 38(5):411-7. PubMed ID: 6328347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular injection of platelet-activating factor induces secretion of adrenocorticotropin, beta-endorphin and corticosterone in conscious rats: a possible link between the immune and nervous systems.
    Rougeot C; Junier MP; Minary P; Weidenfeld J; Braquet P; Dray F
    Neuroendocrinology; 1990 Mar; 51(3):267-75. PubMed ID: 2157993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationships of opioidergic and adrenergic mechanisms controlling the secretion of corticotrophin releasing factor in the rat.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1987 Sep; 46(3):199-206. PubMed ID: 2821423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glucocorticoids on the adrenocortical axis responses to electrical stimulation of the amygdala and the ventral noradrenergic bundle.
    Weidenfeld J; Itzik A; Feldman S
    Brain Res; 1997 Apr; 754(1-2):187-94. PubMed ID: 9134975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adrenergic antagonists and cyclooxygenase inhibitors on the nicotine-induced hypothalamic-pituitary-adrenocortical activity.
    Gadek-Michalska A; Bugajski J; Bugajski AJ; Głód R
    J Physiol Pharmacol; 2002 Jun; 53(2):275-87. PubMed ID: 12120902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.